PCM
HALO icon

Portolan Capital Management’s Halozyme HALO Stock Holding History

Portolan Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-146,239
Closed -$6.1M – 141
2021
Q1 		$6.1M Sell
146,239
-62,661
-30% -$2.86M 0.48% 93
2020
Q4 		$8.92M Sell
208,900
-197,034
-49% -$7.08M 0.81% 45
2020
Q3 		$10.7M Sell
405,934
-127,376
-24% -$3.55M 1.21% 19
2020
Q2 		$14.3M Buy
533,310
+224,040
+72% +$5.05M 1.63% 13
2020
Q1 		$5.56M Buy
+309,270
New +$5.87M 0.83% 41

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Portolan Capital Management's HALO Position: Q2 2021 in Review

Portolan Capital Management sold out of Halozyme (HALO) in Q2 2021, closing a stake of 146,239 shares — an estimated $6.1M sold.

Portolan Capital Management first reported a position in HALO in Q1 2020 and held it in 5 quarters. The position peaked at $14.3M in Q2 2020. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

  • Portolan Capital Management reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
  • Portolan Capital Management sold 146,239 Halozyme shares in Q2 2021, an estimated $6.1M.
  • Portolan Capital Management first reported a position in Halozyme in Q1 2020 and held it in 5 quarters.
  • Portolan Capital Management's Halozyme position peaked at $14.3M in Q2 2020.
  • 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Portolan Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.